203 related articles for article (PubMed ID: 30146180)
1. Transcatheter patent foramen ovale closure versus standard medical therapy for prevention of recurrent stroke: Updated Meta-analysis with an importance on shunt size.
Patel K; Doshi R; Goyal H; Shah P; Meraj P
Eur J Intern Med; 2018 Nov; 57():e31-e33. PubMed ID: 30146180
[No Abstract] [Full Text] [Related]
2. Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials.
Riaz IB; Dhoble A; Mizyed A; Hsu CH; Husnain M; Lee JZ; Lotun K; Lee KS
BMC Cardiovasc Disord; 2013 Dec; 13():116. PubMed ID: 24330204
[TBL] [Abstract][Full Text] [Related]
3. Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials.
Rengifo-Moreno P; Palacios IF; Junpaparp P; Witzke CF; Morris DL; Romero-Corral A
Eur Heart J; 2013 Nov; 34(43):3342-52. PubMed ID: 23847132
[TBL] [Abstract][Full Text] [Related]
4. Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke: a systematic review and meta-analysis.
Khan AR; Bin Abdulhak AA; Sheikh MA; Khan S; Erwin PJ; Tleyjeh I; Khuder S; Eltahawy EA
JACC Cardiovasc Interv; 2013 Dec; 6(12):1316-23. PubMed ID: 24139929
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of patent foramen ovale following cryptogenic stroke: An updated meta-analysis of randomized controlled trials.
Riaz H; Khan MS; Schenone AL; Waheed AA; Khan AR; Krasuski RA
Am Heart J; 2018 May; 199():44-50. PubMed ID: 29754665
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter Closure of Patent Foramen Ovale: Randomized Trial Update.
Arfaras-Melainis A; Palaiodimos L; Mojadidi MK
Interv Cardiol Clin; 2019 Oct; 8(4):341-356. PubMed ID: 31445719
[TBL] [Abstract][Full Text] [Related]
7. Current Dataset for Patent Foramen Ovale Closure in Cryptogenic Stroke: Randomized Clinical Trials and Observational Studies.
Odunukan OW; Price MJ
Interv Cardiol Clin; 2017 Oct; 6(4):525-538. PubMed ID: 28886843
[TBL] [Abstract][Full Text] [Related]
8. Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
Vaduganathan M; Qamar A; Gupta A; Bajaj N; Golwala HB; Pandey A; Bhatt DL
Am J Med; 2018 May; 131(5):575-577. PubMed ID: 29229471
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke: A Meta-Analysis of Randomized Controlled Trials.
Darmoch F; Al-Khadra Y; Soud M; Fanari Z; Alraies MC
Cerebrovasc Dis; 2018; 45(3-4):162-169. PubMed ID: 29597192
[TBL] [Abstract][Full Text] [Related]
10. Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials.
Niu X; Ou-Yang G; Yan PF; Huang SL; Zhang ZT; Zhang ZH
J Neurol; 2018 Jun; 265(6):1259-1268. PubMed ID: 29383514
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter closure of PFO as secondary prevention of cryptogenic stroke.
De Vecchis R; Baldi C; Cantatrione S
Herz; 2017 Feb; 42(1):45-50. PubMed ID: 27255114
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Outcomes after Device Closure and Medication Alone in Patients with Patent Foramen Ovale and Cryptogenic Stroke in Korean Population.
Moon J; Kang WC; Kim S; Oh PC; Park YM; Chung WJ; Choi DY; Lee JY; Lee YB; Hwang HY; Ahn T
Yonsei Med J; 2016 May; 57(3):621-5. PubMed ID: 26996560
[TBL] [Abstract][Full Text] [Related]
13. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.
Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL;
N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism.
Agarwal S; Bajaj NS; Kumbhani DJ; Tuzcu EM; Kapadia SR
JACC Cardiovasc Interv; 2012 Jul; 5(7):777-89. PubMed ID: 22814784
[TBL] [Abstract][Full Text] [Related]
15. close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.
Mas JL; Derumeaux G; Amarenco P; Arquizan C; Aubry P; Barthelet M; Bertrand B; Brochet E; Cabanes L; Donal E; Dubois-Randé JL; Durand-Zaleski I; Ernande L; Finet G; Fraisse A; Giroud M; Guérin P; Habib G; Juliard JM; Leys D; Lièvre M; Lusson JR; Marcon F; Michel P; Moulin T; Mounier-Vehier F; Pierard L; Piot C; Rey C; Rodier G; Roudaut R; Schleich JM; Teiger E; Turc G; Vuillier F; Weimar C; Woimant F; Chatellier G;
Int J Stroke; 2016 Aug; 11(6):724-32. PubMed ID: 27056964
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention.
Leppert MH; Poisson SN; Carroll JD; Thaler DE; Kim CH; Orjuela KD; Ho PM; Burke JF; Campbell JD
Stroke; 2018 Jun; 49(6):1443-1450. PubMed ID: 29720435
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
[TBL] [Abstract][Full Text] [Related]
18. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events.
Pineda AM; Nascimento FO; Yang SC; Kirtane AJ; Sommer RJ; Beohar N
Catheter Cardiovasc Interv; 2013 Nov; 82(6):968-75. PubMed ID: 23832613
[TBL] [Abstract][Full Text] [Related]
20. Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.
Pasceri V; Pelliccia F; Bressi E; Mantione L; Gaudio C; Speciale G; Mehran R; Dangas GD; Patti G
Int J Cardiol; 2018 Sep; 266():75-80. PubMed ID: 29887476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
